Halozyme Therapeutics (HALO) Projected to Post Quarterly Earnings on Tuesday
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) is expected to announce its Q1 2025 earnings results after the market closes on Tuesday, May 6th. Analysts expect Halozyme Therapeutics to post earnings of $0.98 per share and revenue of $231.21 million for the quarter. Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) last issued its quarterly earnings […]
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) is expected to announce its Q1 2025 earnings results after the market closes on Tuesday, May 6th. Analysts expect Halozyme Therapeutics to post earnings of $0.98 per share and revenue of $231.21 million for the quarter. Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) last issued its quarterly earnings […]
